Circadian research reveals promising combination therapy in preventing liver cancer
Recent research from the lab of Kristin Eckel-Mahan, PhD, associate professor in the Institute of Molecular Medicine’s Center for Metabolic and Degenerative Diseases, reveals how a standard therapy for hepatocellular carcinoma (HCC) combined with a natural molecule called nobiletin can…
Pages